SPECT/CT greatly benefits thyroid cancer patients
Article Thumbnail ImageMay 3, 2012 -- SPECT/CT changed postsurgical staging in 21% of patients with thyroid cancer, modified the treatment approach in 36% of those with the disease, and helped avoid unnecessary radiation therapy in 20% of patients with no disease in a study in the May issue of the Journal of Nuclear Medicine.

To get access to this article and all of the content on AuntMinnie.com, create a free account or sign-in now.
(Helptag:PaywallArticleLoginMessage)
Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • Researchers from the University of Michigan Medical Center concluded that the information from SPECT/CT helps to determine the need for radioiodine therapy or alterative options and influences long-term follow-up strategy for patient care.

    Study co-author Dr. Anca Avram said SPECT/CT has substantially improved the interpretation of planar studies and can be implemented in the postoperative management protocols of thyroid cancer patients.

    The findings on scans performed prior to radioiodine therapy altered the recommended sodium iodide I-131 treatment in 58% of patients, compared to therapy based on histopathologic risk stratification alone, by prescribing higher activities for treatment of regional and distant metastases and minimizing the activity prescribed for thyroid remnant ablation.

    SPECT/CT is also very useful for evaluating unusual radioactivity distributions in thyroid cancer patients; accurate anatomic localization of radioactivity foci permits rapid exclusion of physiologic mimics of disease, or confirmation of metastatic lesions to unexpected sites.


    || About || Advertising || AuntMinnieCME.com || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2013 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 AuntMinnie.com. All Rights Reserved.